The role of tumor microenvironment in prostate cancer bone metastasis
- PMID: 17387734
- DOI: 10.1002/jcb.21214
The role of tumor microenvironment in prostate cancer bone metastasis
Abstract
Prostate cancer (PCa) epithelial cells require a number of factors to facilitate their establishment and growth at a distant site of metastasis. Their ability to adapt to their microenvironment, proliferate and recruit an underlying stroma is integral to the survival and growth of the metastasis. PCa predominantly metastasizes to the bone, and bone metastases are the main cause of morbidity. The bone marrow provides a permissive environment for the formation of a metastasis. In some cases, the cells may remain dormant for some time, eventually proliferating in response to an unknown "trigger." The marrow is rich in progenitor cells that differentiate into numerous cell types, producing new blood vessels, supporting fibroblasts, and an underlying extracellular matrix (ECM) that form the reactive stroma. By secreting a number of cytokines, growth factors and proteases they recruit auxiliary cells required to produce a functional stroma. These components are involved in a reciprocal interaction between the stroma and the PCa cells, allowing for the growth and survival of the tumor. Left unchecked, once a PCa tumor has established itself in the bone marrow it will eventually replace the marrow, interrupting bone homeostasis and typically promoting an osteoblastic response in the bone including osteoclastic events. The abundant deposition of new woven bone results in nerve compression, bone pain and an increase in fractures in patients with PCa bone metastases. This review will examine the tumor microenvironment, its role in facilitating tumor dissemination, growth and the resultant pathologies associated with PCa bone metastasis.
Similar articles
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.Urol Oncol. 2007 Sep-Oct;25(5):407-11. doi: 10.1016/j.urolonc.2007.05.008. Urol Oncol. 2007. PMID: 17826661 Review.
-
A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.J Cell Biochem. 2005 Oct 15;96(3):439-46. doi: 10.1002/jcb.20522. J Cell Biochem. 2005. PMID: 15988761 Review.
-
Pathogenesis of osteoblastic bone metastases from prostate cancer.Cancer. 2010 Mar 15;116(6):1406-18. doi: 10.1002/cncr.24896. Cancer. 2010. PMID: 20108337 Review.
-
Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.Differentiation. 2002 Dec;70(9-10):506-21. doi: 10.1046/j.1432-0436.2002.700905.x. Differentiation. 2002. PMID: 12492493 Review.
Cited by
-
Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.Bone. 2015 Sep;78:81-6. doi: 10.1016/j.bone.2015.04.046. Epub 2015 May 5. Bone. 2015. PMID: 25952970 Free PMC article.
-
Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis.Prostate. 2013 Jan;73(1):71-82. doi: 10.1002/pros.22542. Epub 2012 May 29. Prostate. 2013. PMID: 22644942 Free PMC article.
-
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.J Natl Cancer Inst. 2009 Mar 4;101(5):306-20. doi: 10.1093/jnci/djn512. Epub 2009 Feb 24. J Natl Cancer Inst. 2009. PMID: 19244175 Free PMC article. Clinical Trial.
-
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion.Transl Oncol. 2020 Apr;13(4):100747. doi: 10.1016/j.tranon.2020.100747. Epub 2020 Mar 25. Transl Oncol. 2020. PMID: 32217460 Free PMC article.
-
Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.Mol Cancer. 2010 Sep 23;9:258. doi: 10.1186/1476-4598-9-258. Mol Cancer. 2010. PMID: 20863401 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical